Ligand validation:5FVU

W64: 4-methyl-6-(2-(5-(4-methylpiperazin-1-yl)pyridin-3-yl)ethyl)pyridin-2-amine

W64 is a Ligand Of Interest in 5FVU designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5FVU_W64_B_800	84%	39%	0.106	0.968	0.43	1.91	-	12	1	0	100%	1
5FVU_W64_A_800	84%	40%	0.106	0.968	0.39	1.92	-	12	0	0	100%	1
5FVQ_W64_B_800	85%	36%	0.067	0.931	0.49	2	-	11	1	0	100%	1
5G0O_W64_A_800	28%	38%	0.269	0.926	0.38	2	-	10	0	0	100%	1
5FVY_W64_A_800	62%	41%	0.124	0.916	0.46	1.8	-	9	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.